🔎 Trials Near Me

Dachaigh › Cumhaichean Post-COVID (Long COVID) › Washington › Seattle

Sgrùdaidhean clionaigeach Cumhaichean Post-COVID (Long COVID) ann an Seattle, WA

Tha 4 sgrùdaidhean airson Cumhaichean Post-COVID (Long COVID) a’ lorg phàirtichean aig làraichean ann agus timcheall air Seattle (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

A’ fastadhÌre 3
  • Seattle Rheumatology Associates, Seattle
  • Swedish Ambulatory Infusion Center- First Hill, Seattle
  • Swedish Cancer Institute Treatment Center, Seattle
  • agus 6 a bharrachd
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07013474

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

A’ fastadhÌre 3
  • Swedish Medical Center, Seattle
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06631287

A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

A’ fastadhÌre 1
  • GSK Investigational Site, Seattle
Aoisean 65 gu 85 · Gach gnè · Air ùrachadh 30 Ògmh 2026 · NCT07464314

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

A’ fastadhÌre 3
  • Seattle Children's Hospital, Seattle
  • Fred Hutchinson Cancer Center, Seattle
  • Fred Hutchinson Cancer Research Center, Seattle
Gach aois · Gach gnè · Air ùrachadh 23 Ògmh 2026 · NCT03808922

Sgrùdaidhean Cumhaichean Post-COVID (Long COVID) ann am bailtean eile

Sgrùdaidhean eile ann an Seattle

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.